HK Inno.N Corp.
HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers prescription drugs for the treatment of gram-positive and gram-negative organisms, enterococcus faecium infections, vancomycin-resistant, acute bacterial sinusitis, bronchitis, neumonia, antibiotics, and infections caused by microorganism; anemia and hemodialysis; diabetes; hypertension, primary hyperc… Read more
HK Inno.N Corp. (195940) - Total Liabilities
Latest total liabilities as of September 2025: ₩872.89 Billion KRW
Based on the latest financial reports, HK Inno.N Corp. (195940) has total liabilities worth ₩872.89 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
HK Inno.N Corp. - Total Liabilities Trend (2018–2024)
This chart illustrates how HK Inno.N Corp.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
HK Inno.N Corp. Competitors by Total Liabilities
The table below lists competitors of HK Inno.N Corp. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gansu Golden Glass Technologies Co Ltd
SHE:300093
|
China | CN¥4.08 Billion |
|
Jiangsu Lianyungang Port Co Ltd
SHG:601008
|
China | CN¥8.64 Billion |
|
Suzhou Keda Technology Co Ltd
SHG:603660
|
China | CN¥1.27 Billion |
|
Science Environmental Protection Co. Ltd. A
SHG:688480
|
China | CN¥729.82 Million |
|
Zhejiang Transfar Co Ltd
SHE:002010
|
China | CN¥19.41 Billion |
|
Malaysia Building Society Bhd
KLSE:1171
|
Malaysia | RM54.49 Billion |
|
KMRIF
PINK:KMRIF
|
USA | $132.15 Billion |
|
Chutian Dragon Co Ltd
SHE:003040
|
China | CN¥499.03 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down HK Inno.N Corp.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.97 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how HK Inno.N Corp.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for HK Inno.N Corp. (2018–2024)
The table below shows the annual total liabilities of HK Inno.N Corp. from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩638.20 Billion | -0.95% |
| 2023-12-31 | ₩644.34 Billion | +0.85% |
| 2022-12-31 | ₩638.89 Billion | -6.94% |
| 2021-12-31 | ₩686.55 Billion | -21.22% |
| 2020-12-31 | ₩871.44 Billion | -4.59% |
| 2019-12-31 | ₩913.39 Billion | +13.40% |
| 2018-12-31 | ₩805.44 Billion | -- |